Enzymatic and functional correction along with long-term enzyme secretion from transduced bone marrow hematopoietic stem/progenitor and stromal cells derived from patients with Fabry disease
- 1 July 1999
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 27 (7) , 1149-1159
- https://doi.org/10.1016/s0301-472x(99)00050-8
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Isolation of Putative Progenitor Endothelial Cells for AngiogenesisScience, 1997
- CD34: structure, biology, and clinical utility [see comments]Blood, 1996
- Molecular basis of fabry disease: Mutations and polymorphisms in the human α-galactosidase A geneHuman Mutation, 1994
- Metabolic correction and cross-correction of mucopolysaccharidosis type II (Hunter syndrome) by retroviral-mediated gene transfer and expression of human iduronate-2-sulfatase.Proceedings of the National Academy of Sciences, 1993
- Correction of Mucopolysaccharidosis Type I Fibroblasts by Retroviral-Mediated Transfer of the Human α-l-Iduronidase GeneHuman Gene Therapy, 1992
- Correction of glucocerebrosidase deficiency after retroviral-mediated gene transfer into hematopoietic progenitor cells from patients with Gaucher disease.Proceedings of the National Academy of Sciences, 1990
- TRANSPLANTATION IN RELATION TO THE TREATMENT OF INHERITED DISEASETransplantation, 1984
- Neutral glycosphingolipids of serum lipoproteins in Fabry's diseaseBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1976
- Concentrations of glycosyl ceramides in plasma and red cells in Fabry's disease, a glycolipid lipidosisJournal of Lipid Research, 1969
- Enzymatic Defect in Fabry's DiseaseNew England Journal of Medicine, 1967